|
humans |
21 |
|
male |
17 |
|
child, preschool |
16 |
|
female |
16 |
|
adult |
15 |
|
child |
15 |
|
adolescent |
13 |
|
infant |
12 |
|
children |
11 |
|
medical sciences |
11 |
|
chinese |
10 |
|
hong kong |
10 |
|
case-control studies |
8 |
|
epilepsy |
8 |
|
risk factors |
8 |
|
prevalence |
7 |
|
retrospective studies |
7 |
|
autism spectrum disorder (asd) |
6 |
|
cross-sectional studies |
6 |
|
hong kong/epidemiology |
6 |
|
22q11.2 deletion |
5 |
|
age of onset |
5 |
|
analysis of variance |
5 |
|
chinese children |
5 |
|
chronic inflammatory demyelinating polyneuropathy |
5 |
|
congenital heart disease |
5 |
|
cross-cultural comparison |
5 |
|
incidence |
5 |
|
sex factors |
5 |
|
statistics as topic |
5 |
|
*asian continental ancestry group |
4 |
|
*locomotion |
4 |
|
activities of daily living/*classification |
4 |
|
anisotropy |
4 |
|
array comparative genomic hybridization (acgh) |
4 |
|
asian continental ancestry group - genetics |
4 |
|
asian continental ancestry group/*genetics |
4 |
|
cerebral palsy/*diagnosis/epidemiology/rehabilitation |
4 |
|
chemicals and cas registry numbers |
4 |
|
china |
4 |
|
chromosomal proteins, non-histone |
4 |
|
comorbidity |
4 |
|
copy number variations (cnvs) |
4 |
|
dental caries |
4 |
|
diffusion magnetic resonance imaging |
4 |
|
diffusion tensor magnetic resonance imaging |
4 |
|
disability evaluation |
4 |
|
dna-binding proteins - genetics |
4 |
|
dopa-responsive dystonia |
4 |
|
dpp10 |
4 |
|
hand - physiopathology |
4 |
|
heterozygote |
4 |
|
infarction, middle cerebral artery - complications - diagnosis - physiopathology |
4 |
|
internal capsule - pathology |
4 |
|
magnetic resonance imaging |
4 |
|
mental retardation/*diagnosis/epidemiology |
4 |
|
mesencephalon - pathology |
4 |
|
movement |
4 |
|
mutation |
4 |
|
nervous system - physiopathology |
4 |
|
neurologic examination |
4 |
|
neurologic examination/*statistics & numerical data |
4 |
|
neuromotor outcome |
4 |
|
oral health |
4 |
|
paediatric infarction |
4 |
|
paresis - etiology - physiopathology |
4 |
|
periodontal health |
4 |
|
polymorphism, genetic |
4 |
|
pyramidal tracts - pathology |
4 |
|
registries |
4 |
|
self care/classification/*statistics & numerical data |
4 |
|
sensitivity and specificity |
4 |
|
smn2 |
4 |
|
stroke |
4 |
|
syndrome |
4 |
|
thalassemia |
4 |
|
tyrosine hydroxylase deficiency |
4 |
|
wallerian degeneration |
4 |
|
wallerian degeneration - diagnosis - etiology |
4 |
|
*chromosome deletion |
3 |
|
*polymorphism, restriction fragment length |
3 |
|
age factors |
3 |
|
anti-epileptic drugs |
3 |
|
asian continental ancestry group |
3 |
|
attention |
3 |
|
autism spectrum disorders |
3 |
|
becker muscular dystrophy |
3 |
|
blotting, southern |
3 |
|
brain/pathology |
3 |
|
cerebrospinal fluid neurotransmitters |
3 |
|
child development |
3 |
|
china/ethnology |
3 |
|
cohort studies |
3 |
|
cooperation |
3 |
|
csf neurotransmitters |
3 |
|
deficiency diseases - drug therapy |
3 |
|
demography |
3 |
|
densitometry/methods |
3 |
|
developmental profiles |
3 |
|
developmental quotient |
3 |
|
dopamine agents - therapeutic use |
3 |
|
duchenne muscular dystrophy |
3 |
|
dystonia - genetics |
3 |
|
follow-up studies |
3 |
|
frontal lobe - pathology |
3 |
|
functional independence measure for children |
3 |
|
galactorrhea - genetics |
3 |
|
gene mutations |
3 |
|
heterozygote detection |
3 |
|
homovanillic acid |
3 |
|
homovanillic acid - metabolism |
3 |
|
hong kong - epidemiology |
3 |
|
hong kong chinese |
3 |
|
infant, newborn |
3 |
|
integrated approach |
3 |
|
levodopa - therapeutic use |
3 |
|
linkage (genetics)/*genetics |
3 |
|
magnetic resonance spectroscopy |
3 |
|
magnetic resonance spectroscopy - diagnostic use |
3 |
|
methyl-cpg-binding protein 2 |
3 |
|
mitochondrial diseases |
3 |
|
mri |
3 |
|
multigene family/*genetics |
3 |
|
muscle hypotonia - genetics |
3 |
|
muscular dystrophies/*genetics |
3 |
|
mutation/*genetics |
3 |
|
mutation/genetics |
3 |
|
mutational analysis |
3 |
|
nerve tissue proteins - genetics |
3 |
|
neurodevelopmental disorders |
3 |
|
neuromuscular disorders |
3 |
|
neuropsychological tests |
3 |
|
oral health screening |
3 |
|
oral health status |
3 |
|
parents |
3 |
|
parkinsonian disorders - drug therapy - genetics |
3 |
|
pediatric‐onset |
3 |
|
pedigree |
3 |
|
periaqueductal gray - pathology |
3 |
|
phenotype |
3 |
|
pilot projects |
3 |
|
predictive value of tests |
3 |
|
preschool children |
3 |
|
prognosis |
3 |
|
prospective studies |
3 |
|
questionnaires |
3 |
|
references (11) view in table layout |
3 |
|
repressor proteins |
3 |
|
restriction fragment length polymorphism |
3 |
|
rett syndrome - diagnosis - genetics |
3 |
|
seizures |
3 |
|
selegiline - therapeutic use |
3 |
|
sodium channel |
3 |
|
spinal muscular atrophy |
3 |
|
spinal primitive neuroectodermal tumor |
3 |
|
treatment outcome |
3 |
|
tyrosine 3-monooxygenase - deficiency - genetics |
3 |
|
whole‐exome sequencing |
3 |
|
*attitude to health |
2 |
|
*awareness |
2 |
|
*cross-cultural comparison |
2 |
|
*electroencephalography |
2 |
|
*hemoglobin e/genetics |
2 |
|
*hemoglobins, abnormal/genetics |
2 |
|
*magnetic resonance imaging |
2 |
|
*polymorphism, genetic |
2 |
|
*public opinion |
2 |
|
*questionnaires |
2 |
|
3-year-old children |
2 |
|
abcb1 |
2 |
|
abnormalities, multiple/diagnosis |
2 |
|
activities of daily living |
2 |
|
acupuncture |
2 |
|
acupuncture therapy - methods |
2 |
|
acute disseminated encephalomyelitis |
2 |
|
adenoviridae infections - complications |
2 |
|
adult-onset |
2 |
|
aetiology |
2 |
|
age distribution |
2 |
|
aged |
2 |
|
alleles |
2 |
|
alzheimer disease/pathology |
2 |
|
anti-nmdar encephalitis |
2 |
|
anticonvulsants/*adverse effects |
2 |
|
antiepileptic drug |
2 |
|
anxiety |
2 |
|
asian continental ancestry group -genetics |
2 |
|
asian continental ancestry group - genetics - statistics & numerical data |
2 |
|
asian continental ancestry group/genetics |
2 |
|
assembly |
2 |
|
astrocytes/pathology |
2 |
|
autism |
2 |
|
autistic disorder - etiology |
2 |
|
autistic disorder - genetics |
2 |
|
autistic disorder/*diagnosis |
2 |
|
autoantibodies/genetics/immunology |
2 |
|
autoimmune encephalitis |
2 |
|
benzodiazepines |
2 |
|
biopsy |
2 |
|
birth injuries - complications |
2 |
|
blood transfusion |
2 |
|
brain - pathology |
2 |
|
brain diseases - diagnosis - etiology |
2 |
|
brain diseases/complications/pathology |
2 |
|
brain edema/epidemiology/virology |
2 |
|
brain/radiography |
2 |
|
carbamazepine/*adverse effects |
2 |
|
caregiver |
2 |
|
carotid arteries/radiography |
2 |
|
carrier testing |
2 |
|
central nervous system diseases - complications - rehabilitation |
2 |
|
central nervous system infections - complications |
2 |
|
cerebellum - pathology |
2 |
|
cerebral angiography |
2 |
|
cerebral cortex - pathology |
2 |
|
cerebral infarction |
2 |
|
cerebral infarction/etiology |
2 |
|
cerebral palsy - complications - rehabilitation |
2 |
|
cerebrovascular disorders |
2 |
|
child behavior disorders - diagnosis - epidemiology |
2 |
|
child day care centers |
2 |
|
childhood |
2 |
|
china - epidemiology |
2 |
|
china/epidemiology |
2 |
|
chinese culture |
2 |
|
cholesterol biosynthesis |
2 |
|
clinical assessment |
2 |
|
clinical outcome |
2 |
|
clinical trial |
2 |
|
codon, nonsense |
2 |
|
complex i |
2 |
|
compound heterozygous mutation |
2 |
|
coping style |
2 |
|
cost-benefit analysis |
2 |
|
cross-over studies |
2 |
|
cyclic amp response element-binding protein |
2 |
|
data collection |
2 |
|
deglutition disorders - etiology - radiography - rehabilitation |
2 |
|
delay |
2 |
|
depression |
2 |
|
developmental delay (dd) |
2 |
|
developmental disabilities |
2 |
|
developmental disabilities - complications - rehabilitation |
2 |
|
diagnosis, differential |
2 |
|
diffusion-weighted imaging |
2 |
|
disease progression |
2 |
|
disease severity |
2 |
|
dna mutational analysis |
2 |
|
dna-binding proteins/*genetics |
2 |
|
dominance, cerebral - physiology |
2 |
|
down syndrome - complications - rehabilitation |
2 |
|
drug resistance |
2 |
|
dystonia/diagnosis/genetics/physiopathology |
2 |
|
eating disorders/*complications |
2 |
|
electric stimulation |
2 |
|
encephalitis |
2 |
|
encephalitis, viral/epidemiology/etiology |
2 |
|
encephalomyelitis, acute disseminated - pathology |
2 |
|
encephalopathy |
2 |
|
environmental exposure |
2 |
|
environmental pollutants - adverse effects - analysis |
2 |
|
environmental pollutants - adverse effects - blood |
2 |
|
epidemiologic methods |
2 |
|
epidemiology |
2 |
|
epidermal necrolysis, toxic/*drug therapy/*etiology |
2 |
|
epilepsy - diagnosis - epidemiology |
2 |
|
epilepsy/ethnology/*psychology |
2 |
|
epileptic encephalopathy |
2 |
|
ethnic groups/*statistics & numerical data |
2 |
|
evidence based |
2 |
|
evoked potentials, auditory, brain stem/*physiology |
2 |
|
evoked potentials, auditory, brain stem/physiology |
2 |
|
evoked potentials, somatosensory/physiology |
2 |
|
extramedullary hematopoiesis |
2 |
|
family health |
2 |
|
fibromyalgia |
2 |
|
fish |
2 |
|
fluoroscopy - methods |
2 |
|
folinic acid responsive epilepsy |
2 |
|
fragile x |
2 |
|
fraxa |
2 |
|
fraxe |
2 |
|
functional independence measure |
2 |
|
gaba agonists/therapeutic use |
2 |
|
gamma-aminobutyric acid/metabolism |
2 |
|
gene deletion |
2 |
|
gene frequency |
2 |
|
gene frequency/genetics |
2 |
|
genetic predisposition to disease/*genetics |
2 |
|
genetic testing |
2 |
|
genetic variation/genetics |
2 |
|
genotype |
2 |
|
global developmental delay |
2 |
|
global developmental delay (gdd) |
2 |
|
globus pallidus - pathology |
2 |
|
glucocorticoids/*administration & dosage |
2 |
|
glutamate decarboxylase/immunology |
2 |
|
griffiths development scales |
2 |
|
haplotypes |
2 |
|
hematoma, subdural - complications - rehabilitation |
2 |
|
hematopoiesis, extramedullary |
2 |
|
histocompatibility testing |
2 |
|
hla antigens/genetics |
2 |
|
hla-b antigens/genetics |
2 |
|
hla-dr antigens/*genetics |
2 |
|
hong kong - ethnology |
2 |
|
hospitalization |
2 |
|
hypoxia, brain - diagnosis - etiology |
2 |
|
infant, newborn, diseases - diagnosis - etiology |
2 |
|
influenza, human - complications |
2 |
|
influenza, human/*complications/epidemiology |
2 |
|
infusions, intravenous |
2 |
|
intellectual disability (id) |
2 |
|
intellectual disability - diagnosis |
2 |
|
intellectual disability - diagnosis - epidemiology |
2 |
|
intelligence - physiology |
2 |
|
intracranial embolism and thrombosis/*complications/radiography |
2 |
|
intractable epilepsy |
2 |
|
language |
2 |
|
language comprehension |
2 |
|
language delay |
2 |
|
language development |
2 |
|
language development disorders - etiology - psychology |
2 |
|
language expression |
2 |
|
likelihood ratio model |
2 |
|
london - epidemiology |
2 |
|
magnetic resonance imaging - methods |
2 |
|
magnetic resonance imaging - statistics & numerical data |
2 |
|
mass screening |
2 |
|
maximum allowable concentration |
2 |
|
memory disorders/*complications |
2 |
|
mental retardation (mr) |
2 |
|
mercury |
2 |
|
mercury - adverse effects - blood |
2 |
|
mercury - analysis - toxicity |
2 |
|
metabolism, inborn errors - complications |
2 |
|
methylprednisolone/*administration & dosage |
2 |
|
middle aged |
2 |
|
molecular chaperones/*genetics |
2 |
|
mood disorders/*complications |
2 |
|
multilingualism |
2 |
|
muscle spasticity/diagnosis/genetics/physiopathology |
2 |
|
muscle, skeletal/innervation/*physiopathology |
2 |
|
muscular atrophy, spinal - epidemiology - genetics |
2 |
|
muscular atrophy, spinal - genetics |
2 |
|
myasthenia gravis |
2 |
|
myasthenia gravis/diagnosis/*epidemiology/genetics |
2 |
|
myasthenia gravis/epidemiology/*genetics |
2 |
|
ndufa9 |
2 |
|
neonate |
2 |
|
neural conduction/physiology |
2 |
|
neurofibromatosis 1 - diagnosis |
2 |
|
neuroimmunology |
2 |
|
neuronal apoptosis-inhibitory protein |
2 |
|
nmdar antibody |
2 |
|
occupations |
2 |
|
ohtahara syndrome |
2 |
|
olivopontocerebellar atrophies - complications - rehabilitation |
2 |
|
outcome assessment (health care) |
2 |
|
oxphos |
2 |
|
p-glycoprotein |
2 |
|
partial developmental delay (pardd) |
2 |
|
paternal age |
2 |
|
pediatrics |
2 |
|
peripheral nervous system neoplasms - diagnosis |
2 |
|
pharmacogenetic |
2 |
|
pharmacogenetics |
2 |
|
plasmapheresis |
2 |
|
play and playthings |
2 |
|
point mutation |
2 |
|
pregnancy |
2 |
|
psychiatric status rating scales |
2 |
|
psychiatric-disorder |
2 |
|
psychological tests |
2 |
|
psychology, social |
2 |
|
psychosocial adjustment |
2 |
|
pulse therapy, drug |
2 |
|
qpcr |
2 |
|
reaction time/physiology |
2 |
|
receptors, cholinergic/*immunology |
2 |
|
recurrence |
2 |
|
reference values |
2 |
|
regression analysis |
2 |
|
respiratory insufficiency/*genetics |
2 |
|
retardation |
2 |
|
rna-binding proteins |
2 |
|
sampling studies |
2 |
|
schools |
2 |
|
seafood - adverse effects |
2 |
|
seizure |
2 |
|
seizures, febrile - genetics - virology |
2 |
|
seizures, febrile/*epidemiology/ethnology/etiology |
2 |
|
seizures, febrile/epidemiology/*virology |
2 |
|
severity of illness index |
2 |
|
sexual dysfunction, physiological/*complications |
2 |
|
simvastatin treatment |
2 |
|
single-blind method |
2 |
|
sma |
2 |
|
sma carriers |
2 |
|
smn complex proteins |
2 |
|
smn1 |
2 |
|
smni |
2 |
|
social behavior |
2 |
|
social class |
2 |
|
spasms, infantile - diagnosis - epidemiology |
2 |
|
speech |
2 |
|
spinal cord - pathology |
2 |
|
spinal cord compression |
2 |
|
spinal cord compression - etiology - therapy |
2 |
|
spinal cord neoplasms - diagnosis |
2 |
|
spinal muscular atrophies of childhood/complications/*diagnosis/*genetics |
2 |
|
spinal nerves - pathology |
2 |
|
status epilepticus |
2 |
|
stiff-person syndrome/diagnosis/*genetics/*physiopathology |
2 |
|
stroke - diagnosis - etiology |
2 |
|
stroke/*ethnology/etiology |
2 |
|
stxbp1 mutations |
2 |
|
survival of motor neuron 1 protein |
2 |
|
survival of motor neuron 2 protein |
2 |
|
tandem repeat sequences/genetics |
2 |
|
teaching |
2 |
|
thalamus - pathology |
2 |
|
thalassemia - complications |
2 |
|
thalassemia/*complications/genetics |
2 |
|
threshold limit values |
2 |
|
thymoma/diagnosis/epidemiology/genetics |
2 |
|
thymus neoplasms/diagnosis/epidemiology/genetics |
2 |
|
tomography, x-ray computed |
2 |
|
tongue |
2 |
|
total sterol |
2 |
|
transcription factors/*genetics |
2 |
|
transfusion |
2 |
|
tuberous sclerosis - diagnosis - epidemiology - genetics |
2 |
|
united states/epidemiology |
2 |
|
video recording |
2 |
|
video-fluoroscopic study of swallowing |
2 |
|
virus diseases - complications |
2 |
|
washington psychosocial inventory |
2 |
|
wechsler scales |
2 |
|
weefim |
2 |
|
west syndrome |
2 |
|
*activities of daily living |
1 |
|
*acupuncture therapy |
1 |
|
*arm |
1 |
|
*asian continental ancestry group/psychology/statistics & numerical data |
1 |
|
*caregivers |
1 |
|
*child care |
1 |
|
*child development |
1 |
|
*cooking and eating utensils |
1 |
|
*disability evaluation |
1 |
|
*dna mutational analysis |
1 |
|
*echoencephalography |
1 |
|
*electroacupuncture |
1 |
|
*ethnic groups |
1 |
|
*evoked potentials, visual/radiation effects |
1 |
|
*ganglioneuroma/diagnosis/pathology/surgery |
1 |
|
*gene frequency |
1 |
|
*genetic predisposition to disease |
1 |
|
*health status |
1 |
|
*health status indicators |
1 |
|
*hemolysis |
1 |
|
*image enhancement |
1 |
|
*international classification of diseases |
1 |
|
*language development |
1 |
|
*language tests |
1 |
|
*major histocompatibility complex |
1 |
|
*mass screening |
1 |
|
*mass screening/methods |
1 |
|
*medicine, chinese traditional |
1 |
|
*motor skills |
1 |
|
*narcolepsy/diagnosis |
1 |
|
*neuropsychological tests |
1 |
|
*outcome assessment (health care) |
1 |
|
*play and playthings |
1 |
|
*prenatal exposure delayed effects |
1 |
|
*quality of life |
1 |
|
*spinal cord neoplasms/diagnosis/pathology/surgery |
1 |
|
*symbolism |
1 |
|
*tomography, x-ray computed |
1 |
|
*tongue |
1 |
|
*trinucleotide repeats |
1 |
|
abcc2 |
1 |
|
abcc5 |
1 |
|
abcg2 |
1 |
|
abortion, habitual/chemically induced |
1 |
|
achondroplasia/*diagnosis |
1 |
|
acoustic stimulation |
1 |
|
action potentials |
1 |
|
acupressure - methods |
1 |
|
acupuncture - methods |
1 |
|
acupuncture points |
1 |
|
acupuncture therapy [*methods] |
1 |
|
acupuncture therapy [methods] |
1 |
|
acupuncture therapy/*methods |
1 |
|
acupuncture. |
1 |
|
acute disease |
1 |
|
acute inflammatory demyelinating polyradiculoneuropathy |
1 |
|
acute viral encephalitis |
1 |
|
adrenoleukodystrophy |
1 |
|
adrenoleukodystrophy/diet therapy/drug therapy/*pathology |
1 |
|
adverse event |
1 |
|
adverse outcome |
1 |
|
aefi |
1 |
|
aged, 80 and over |
1 |
|
alternating hemiplegia |
1 |
|
alternative medicine |
1 |
|
amino acid substitution |
1 |
|
amniotic band syndrome/complications/diagnosis |
1 |
|
analgesics/therapeutic use |
1 |
|
anesthesia, general/adverse effects |
1 |
|
anesthesia, obstetrical/adverse effects |
1 |
|
animals |
1 |
|
animals, newborn |
1 |
|
annual incidence |
1 |
|
anterior cingulate |
1 |
|
anti-anxiety agents/*therapeutic use |
1 |
|
anti-inflammatory agents/administration & dosage |
1 |
|
anti-inflammatory agents/therapeutic use |
1 |
|
anticoagulant |
1 |
|
anticonvulsants/administration & dosage/*adverse effects |
1 |
|
anticonvulsants/adverse effects/*therapeutic use |
1 |
|
anticonvulsants/therapeutic use |
1 |
|
antiepileptic drugs |
1 |
|
apraxias - genetics |
1 |
|
arm/*abnormalities |
1 |
|
arrhythmias, cardiac/etiology |
1 |
|
arthrogryposis multiplex congenita |
1 |
|
arthrogryposis/*classification/complications/mortality |
1 |
|
asia/epidemiology |
1 |
|
asian continental ancestry group/*psychology |
1 |
|
asian continental ancestry group/*psychology/statistics & numerical data |
1 |
|
asian continental ancestry group/*statistics & numerical data |
1 |
|
aspartic acid/analogs & derivatives/analysis |
1 |
|
asperger syndrome |
1 |
|
asperger syndrome/diagnosis/psychology/*rehabilitation |
1 |
|
assessment |
1 |
|
association |
1 |
|
ataxia telangiectasia (louis bar syndrome) |
1 |
|
ataxia telangiectasia/*physiopathology |
1 |
|
atp-binding cassette transporters - genetics |
1 |
|
atp1a3 |
1 |
|
atrophy |
1 |
|
attention deficit disorder with hyperactivity/*blood/epidemiology |
1 |
|
attention deficit disorder with hyperactivity/*genetics |
1 |
|
attention deficit disorder with hyperactivity/enzymology/*genetics |
1 |
|
attention deficit hyperactivity disorder (adhd) |
1 |
|
attention-deficit hyperactivity disorder (adhd) |
1 |
|
auditory pathways/*growth & development |
1 |
|
auditory pathways/physiopathology |
1 |
|
autism diagnostic observation schedule (ados) |
1 |
|
autism in children -- treatment. |
1 |
|
autism spectrum disorder |
1 |
|
autistic disorder |
1 |
|
autistic disorder - complications - therapy |
1 |
|
autistic disorder - therapy |
1 |
|
autistic disorder/*epidemiology |
1 |
|
autistic disorder/*pathology |
1 |
|
autistic disorder/complications/diagnosis/*physiopathology |
1 |
|
autistic disorder/diagnosis/*epidemiology/genetics |
1 |
|
autistic disorder/diagnosis/*genetics |
1 |
|
autistic disorder/diagnosis/*physiopathology/psychology |
1 |
|
autistic disorder/diagnosis/epidemiology/psychology/*rehabilitation |
1 |
|
autistic disorder/psychology/*therapy |
1 |
|
autistic spectrum disorder (asd) |
1 |
|
autoantibodies/immunology |
1 |
|
autoimmune diseases |
1 |
|
autosomal dominant |
1 |
|
behavior change |
1 |
|
behavior disorder |
1 |
|
behavior therapy |
1 |
|
bell palsy - therapy |
1 |
|
bell palsy/*diagnosis/drug therapy/etiology/pathology/*physiopathology |
1 |
|
bell palsy/diagnosis/*etiology/virology |
1 |
|
bell's palsy |
1 |
|
beta-thalassemia/blood/*drug therapy |
1 |
|
betamethasone/therapeutic use |
1 |
|
biliary atresia |
1 |
|
bilirubin/blood |
1 |
|
blindness/congenital/*etiology/physiopathology |
1 |
|
blink reflex |
1 |
|
blinking/physiology |
1 |
|
botox (allergan) |
1 |
|
botulinum toxin type a (btx) |
1 |
|
botulinum toxin type a/*administration & dosage/adverse effects |
1 |
|
botulinum toxin type a/*therapeutic use |
1 |
|
brachial plexus neuropathies/etiology |
1 |
|
bradycardia/etiology |
1 |
|
brain |
1 |
|
brain - blood supply - pathology - physiopathology |
1 |
|
brain - physiology |
1 |
|
brain damage, chronic/complications/physiopathology |
1 |
|
brain diseases/*chemically induced |
1 |
|
brain diseases/complications |
1 |
|
brain edema/pathology |
1 |
|
brain injuries |
1 |
|
brain injuries - rehabilitation - therapy |
1 |
|
brain mapping |
1 |
|
brain stem/*physiopathology |
1 |
|
brain/*growth & development/physiology |
1 |
|
brain/*metabolism/radionuclide imaging |
1 |
|
brain/drug effects |
1 |
|
brain/physiopathology/radiography |
1 |
|
brainstem auditory evoked potential (baep) |
1 |
|
canada/epidemiology |
1 |
|
canadian |
1 |
|
cantonese |
1 |
|
case definition |
1 |
|
case-control study |
1 |
|
catechol o-methyltransferase/*genetics |
1 |
|
catechol-o- methyltransferase (comt) |
1 |
|
cdkl5-epileptic encephalopathy |
1 |
|
cephalometry |
1 |
|
cerebellar atrophy |
1 |
|
cerebellum/physiology |
1 |
|
cerebral cortex/drug effects/metabolism/pathology |
1 |
|
cerebral cortex/pathology/ultrasonography |
1 |
|
cerebral palsy |
1 |
|
cerebral palsy (cp) |
1 |
|
cerebral palsy - complications - therapy |
1 |
|
cerebral palsy - pathology - therapy |
1 |
|
cerebral palsy/*drug therapy |
1 |
|
cerebral palsy/*metabolism/radionuclide imaging/*therapy |
1 |
|
cerebral ventricles/pathology |
1 |
|
cerebrovascular circulation |
1 |
|
cervical vertebrae/abnormalities/pathology |
1 |
|
cesarean section |
1 |
|
chi-square distribution |
1 |
|
child - preschool |
1 |
|
child behavior - psychology |
1 |
|
child behavior disorders - etiology - therapy |
1 |
|
child behavior/*ethnology/*physiology |
1 |
|
child behavior/physiology/*psychology |
1 |
|
child development disorders - pervasive/*therapy |
1 |
|
child development/*classification/physiology |
1 |
|
child development/*physiology |
1 |
|
child of impaired parents/psychology |
1 |
|
child psychiatry |
1 |
|
child, hospitalized/*statistics & numerical data |
1 |
|
children and youth |
1 |
|
chinese herbal [therapeutic use] |
1 |
|
chloral hydrate |
1 |
|
choline/analysis |
1 |
|
cholinesterase inhibitors/therapeutic use |
1 |
|
chopsticks |
1 |
|
chromosome inversion |
1 |
|
chromosomes, human, pair 15/genetics |
1 |
|
chromosomes, human, pair 7 - genetics |
1 |
|
clinical definition |
1 |
|
clinical trials |
1 |
|
cognition/*physiology |
1 |
|
cognition/physiology |
1 |
|
combined modality therapy |
1 |
|
communication |
1 |
|
community mental health services/*organization & administration |
1 |
|
complement system proteins/genetics |
1 |
|
complementary and alternative medicine (cam) |
1 |
|
complementary therapies - classification - ethics - methods |
1 |
|
congenital myasthenic syndromes |
1 |
|
congenital prosopagnosia (cpa) |
1 |
|
consanguinity |
1 |
|
conscious sedation |
1 |
|
consensus |
1 |
|
conserve oligomeric golgi |
1 |
|
contracture |
1 |
|
copper/analysis/blood/metabolism |
1 |
|
corticosteroid |
1 |
|
cross-cultural difference |
1 |
|
cutis laxa |
1 |
|
cutis marmorata telangiectatica congenita |
1 |
|
cystathionine beta-synthase/antagonists & inhibitors |
1 |
|
cystathionine-β-synthase |
1 |
|
data interpretation, statistical |
1 |
|
deafness/etiology |
1 |
|
deferoxamine/pharmacology/*therapeutic use |
1 |
|
delphi technique |
1 |
|
development |
1 |
|
developmental disabilities - therapy |
1 |
|
developmental disabilities/*complications |
1 |
|
developmental disabilities/*diagnosis/*epidemiology |
1 |
|
developmental disabilities/*diagnosis/epidemiology |
1 |
|
developmental disabilities/*genetics |
1 |
|
developmental disabilities/*physiopathology/*psychology |
1 |
|
developmental disabilities/*rehabilitation |
1 |
|
developmental disabilities/classification/diagnosis |
1 |
|
developmental disabilities/complications/diagnosis/physiopathology |
1 |
|
developmental disabilities/etiology |
1 |
|
diabetes mellitus/blood/metabolism |
1 |
|
diagnostic and statistical manual of mental disorders |
1 |
|
diagnostics |
1 |
|
diarrhea |
1 |
|
diarrhea - chemically induced - diagnosis |
1 |
|
dilatation, pathologic |
1 |
|
disabilities |
1 |
|
diseases/diagnosis/*genetics |
1 |
|
dominance, cerebral/physiology |
1 |
|
dopamine d4 receptor (drd4) |
1 |
|
dopamine plasma membrane transport proteins/*genetics |
1 |
|
dopamine transporter |
1 |
|
dose-response relationship, drug |
1 |
|
double blind procedure |
1 |
|
down syndrome |
1 |
|
down syndrome/*complications |
1 |
|
down syndrome/*complications/ethnology/genetics |
1 |
|
down syndrome/diagnosis/*physiopathology |
1 |
|
drooling |
1 |
|
drug administration schedule |
1 |
|
drug resistance, multiple - genetics |
1 |
|
drug resistance/*genetics |
1 |
|
drug therapy, combination |
1 |
|
drug transporters |
1 |
|
drugs |
1 |
|
drugs, chinese herbal - therapeutic use |
1 |
|
drugs, chinese herbal [therapeutic use] |
1 |
|
drugs, chinese herbal/therapeutic use |
1 |
|
dysmorphology |
1 |
|
dysport (ipsen) |
1 |
|
early diagnosis |
1 |
|
early identification |
1 |
|
early intervention |
1 |
|
eating |
1 |
|
education |
1 |
|
education, special/*organization & administration |
1 |
|
eeg |
1 |
|
electro-acupuncture |
1 |
|
electroacupuncture |
1 |
|
electroacupuncture - methods |
1 |
|
electroencephalography |
1 |
|
electroencephalography/standards/statistics & numerical data |
1 |
|
electromyography |
1 |
|
electronic mail |
1 |
|
electrooculography |
1 |
|
electrophoresis, agar gel |
1 |
|
electrophysiological studies |
1 |
|
electrophysiology |
1 |
|
electroretinography |
1 |
|
embryopathy |
1 |
|
emergency service, hospital - utilization |
1 |
|
emigration and immigration |
1 |
|
emotional disorder |
1 |
|
employment |
1 |
|
encephalitis viruses/isolation & purification |
1 |
|
encephalitis/cerebrospinal |
1 |
|
encephalo-myelo-radiculo-neuropathy |
1 |
|
epidemiologic studies |
1 |
|
epilepsy - drug therapy - genetics |
1 |
|
epilepsy - therapy |
1 |
|
epilepsy [*therapy] |
1 |
|
epilepsy [therapy] |
1 |
|
epilepsy/*epidemiology |
1 |
|
epilepsy/*epidemiology/*psychology |
1 |
|
epilepsy/*epidemiology/etiology/therapy |
1 |
|
epilepsy/*etiology |
1 |
|
epilepsy/*therapy |
1 |
|
epilepsy/classification/complications/*diagnosis/*drug |
1 |
|
epilepsy/complications/*drug therapy/psychology |
1 |
|
epilepsy/diagnosis |
1 |
|
epilepsy/diagnosis/*physiopathology |
1 |
|
epilepsy/drug therapy/ethnology/*genetics |
1 |
|
epilepsy/drug therapy/genetics |
1 |
|
epilepsy/etiology |
1 |
|
epileptic |
1 |
|
erucic acid |
1 |
|
erucic acids/therapeutic use |
1 |
|
eukaryotic initiation factor-2b/*genetics |
1 |
|
europe/epidemiology |
1 |
|
evidence-based medicine |
1 |
|
evoked potentials |
1 |
|
evoked potentials, auditory, brain stem |
1 |
|
evoked potentials, visual/*physiology |
1 |
|
evoked potentials, visual/physiology |
1 |
|
evoked potentials/drug effects |
1 |
|
evolution |
1 |
|
evolution, molecular |
1 |
|
exchange transfusion, whole blood |
1 |
|
exons/*genetics |
1 |
|
eye |
1 |
|
eye abnormalities/epidemiology/*etiology |
1 |
|
face blindness |
1 |
|
facial expression |
1 |
|
facial nerve |
1 |
|
facial nerve palsy |
1 |
|
facial nerve/physiology |
1 |
|
facial paralysis/physiopathology/*therapy |
1 |
|
facies |
1 |
|
fathers |
1 |
|
febrile seizures |
1 |
|
feeding behavior/*physiology |
1 |
|
ferritins/analysis/blood/metabolism |
1 |
|
fetal alcohol syndrome/complications/diagnosis |
1 |
|
fetal diseases/*chemically induced |
1 |
|
fetal diseases/genetics/physiopathology |
1 |
|
fetal growth retardation - genetics |
1 |
|
fludrocortisone/therapeutic use |
1 |
|
fluid/diagnosis/*etiology/microbiology/mortality |
1 |
|
fluorodeoxyglucose f18/diagnostic use |
1 |
|
flushing/etiology |
1 |
|
forkhead transcription factors - genetics |
1 |
|
founder effect |
1 |
|
fragile x syndrome/diagnosis/*genetics |
1 |
|
fructosamine |
1 |
|
fructose/administration & dosage/*adverse effects/*analogs & derivatives |
1 |
|
functional magnetic resonance imaging (fmri) |
1 |
|
gait/drug effects |
1 |
|
gamma-aminobutyric acid/adverse effects/*analogs & derivatives/therapeutic |
1 |
|
gamma-globulins/therapeutic use |
1 |
|
gammaglobulin |
1 |
|
ganglia, spinal/physiopathology |
1 |
|
gangliocytoma |
1 |
|
ganglioglioma |
1 |
|
ganglioneuroma |
1 |
|
gastroenteritis/*complications |
1 |
|
gene frequency/*genetics |
1 |
|
genes, dominant |
1 |
|
genetic counseling |
1 |
|
genetic markers/genetics |
1 |
|
genetic polymorphisms |
1 |
|
genetic predisposition to disease |
1 |
|
genetic testing/*methods |
1 |
|
gestational age |
1 |
|
glucocorticoids/therapeutic use |
1 |
|
glucose/*metabolism |
1 |
|
glucose/metabolism |
1 |
|
gross motor function measure |
1 |
|
guidelines |
1 |
|
guillain-barre syndrome |
1 |
|
guillain-barre syndrome - classification - drug therapy - epidemiology - ethnology |
1 |
|
haplotype |
1 |
|
headache disorders/*classification/*diagnosis/epidemiology/psychology |
1 |
|
health care |
1 |
|
health care reform/*organization & administration/trends |
1 |
|
hearing disorders/*diagnosis/epidemiology/*etiology |
1 |
|
hearing disorders/*etiology |
1 |
|
hearing impairment |
1 |
|
hearing/physiology |
1 |
|
heart arrest/etiology |
1 |
|
heart catheterization/*adverse effects |
1 |
|
heart defects, congenital/*diagnosis/*therapy |
1 |
|
hemiplegia/drug therapy/*physiopathology/radionuclide imaging |
1 |
|
hemiplegia/etiology |
1 |
|
heparin |
1 |
|
heparin/*adverse effects/therapeutic use |
1 |
|
hepatocellular carcinoma |
1 |
|
herbal medicine - ethics - methods |
1 |
|
hereditary central nervous system demyelinating |
1 |
|
hereditary prosopagnosia (hpa) |
1 |
|
hexosamines/analysis/blood/metabolism |
1 |
|
homozygote |
1 |
|
hong kong/epidemiology/ethnology |
1 |
|
hong kong/ethnology |
1 |
|
hospitalization - statistics and numerical data |
1 |
|
hydrocortisone/therapeutic use |
1 |
|
hydrogen sulfide |
1 |
|
hydrogen sulfide/*metabolism |
1 |
|
hydroxylamine/therapeutic use |
1 |
|
hyperammonemia/*chemically induced |
1 |
|
hyperbilirubinemia, neonatal/blood/*physiopathology/therapy |
1 |
|
hyperbilirubinemia, neonatal/ethnology/*physiopathology |
1 |
|
hyperbilirubinemia/*physiopathology/*therapy |
1 |
|
hypoxia-ischemia |
1 |
|
hypoxia-ischemia, brain/metabolism/physiopathology/*prevention & control |
1 |
|
hypoxic-ischemic brain-damage |
1 |
|
icf |
1 |
|
icf core set |
1 |
|
immunization |
1 |
|
immunization - adverse effects |
1 |
|
immunization/*adverse effects |
1 |
|
immunoglobulin |
1 |
|
infant, newborn, diseases/*chemically induced |
1 |
|
infantile epileptic encephalopathy (iee) |
1 |
|
infantile spasm |
1 |
|
infantile spasm (is) |
1 |
|
infantile spasms |
1 |
|
inhibitory control |
1 |
|
injections, intramuscular |
1 |
|
integrative medicine - ethics - methods |
1 |
|
intelligent quotient |
1 |
|
international classification of diseases |
1 |
|
interpersonal relations |
1 |
|
interviews as topic |
1 |
|
ion channel gating/genetics |
1 |
|
japan |
1 |
|
japan/epidemiology |
1 |
|
japan/ethnology |
1 |
|
jaw |
1 |
|
juvenile-onset |
1 |
|
lactic acid/analysis |
1 |
|
language development disorders/*epidemiology |
1 |
|
language development disorders/diagnosis/psychology/rehabilitation |
1 |
|
language disorders/complications/diagnosis/physiopathology |
1 |
|
language tests/*standards/*statistics & numerical data |
1 |
|
language tests/statistics & numerical data |
1 |
|
lead poisoning/pathology/*physiopathology |
1 |
|
leg/*abnormalities |
1 |
|
leukoencephalopathy |
1 |
|
light/adverse effects |
1 |
|
linkage disequilibrium |
1 |
|
locus control region |
1 |
|
logistic models |
1 |
|
lumbar vertebrae/*ultrasonography |
1 |
|
lumbosacral region/ultrasonography |
1 |
|
machado-joseph disease - ethnology - genetics |
1 |
|
machado-joseph disease/*epidemiology/*genetics |
1 |
|
machado-joseph disease/*genetics |
1 |
|
mandarin |
1 |
|
matched-pair analysis |
1 |
|
mdr1 |
1 |
|
mecp2 mutation |
1 |
|
medicine, chinese traditional |
1 |
|
meningitis/complications/*physiopathology |
1 |
|
mental health |
1 |
|
mental retardation |
1 |
|
mental retardation/*etiology |
1 |
|
mental retardation/complications/diagnosis |
1 |
|
mental retardation/complications/physiopathology |
1 |
|
mental retardation/diagnosis/genetics |
1 |
|
mental retardation/diagnosis/physiopathology/psychology |
1 |
|
mercury/*blood |
1 |
|
meta-analysis |
1 |
|
metabolism, inborn errors |
1 |
|
methionine |
1 |
|
methyl-cpg-binding protein 2/*genetics |
1 |
|
microcephaly/*etiology |
1 |
|
microscopy, electron |
1 |
|
migraine disorders/*diagnosis/drug therapy |
1 |
|
migraine without aura/classification/diagnosis/epidemiology/psychology |
1 |
|
miller fisher syndrome |
1 |
|
minisatellite repeats/*genetics |
1 |
|
modified atkins diet |
1 |
|
molecular sequence data |
1 |
|
monoatrophy |
1 |
|
motor activity/*physiology |
1 |
|
motor activity/physiology |
1 |
|
motor skills/drug effects |
1 |
|
movements |
1 |
|
multidrug resistance-associated proteins - genetics |
1 |
|
multiple sclerosis - epidemiology - physiopathology |
1 |
|
muscle spasticity |
1 |
|
muscle spasticity/*drug therapy |
1 |
|
muscle strength |
1 |
|
muscular dystrophies/complications/diagnosis |
1 |
|
muscular dystrophy, duchenne [*complications] |
1 |
|
muscular dystrophy, duchenne/*complications |
1 |
|
mutation - genetics |
1 |
|
mutation/*physiology |
1 |
|
myasthenia gravis. |
1 |
|
myasthenia gravis/*genetics/immunology |
1 |
|
myasthenia gravis/congenital/diagnosis/*epidemiology |
1 |
|
mycoplasma infection |
1 |
|
myelination |
1 |
|
myotonia/complications/diagnosis |
1 |
|
myotonic dystrophy/congenital/*diagnosis |
1 |
|
na, k-atpase |
1 |
|
neoplasm proteins - genetics |
1 |
|
nerve conduction velocity (ncv) |
1 |
|
nerve tissue proteins/*genetics |
1 |
|
nervous system diseases/*etiology |
1 |
|
nervous system diseases/*genetics |
1 |
|
neural conduction |
1 |
|
neural pathways/drug effects |
1 |
|
neural tube defects/*ultrasonography |
1 |
|
neuralgia/diagnosis/epidemiology/genetics/*physiopathology |
1 |
|
neurodevelopment |
1 |
|
neurodevelopmental disorder |
1 |
|
neurodevelopmental disorders, children |
1 |
|
neurodevelopmental profile |
1 |
|
neurofibromatosis 1/*diagnosis/ethnology/genetics |
1 |
|
neurohabilitation |
1 |
|
neurologic examination/drug effects |
1 |
|
neurologic examination/methods |
1 |
|
neuromuscular agents/*therapeutic use |
1 |
|
neuromuscular junction |
1 |
|
next-generation sequencing |
1 |
|
nociceptors/physiology |
1 |
|
non-epileptic |
1 |
|
nonsyndromal mental retardation |
1 |
|
nonverbal communication/psychology |
1 |
|
nuclear proteins - genetics |
1 |
|
nuclear proteins/*genetics |
1 |
|
occipital lobe/*pathology |
1 |
|
occipital lobe/metabolism/radionuclide imaging |
1 |
|
ocular features |
1 |
|
oculomotor nerve/*pathology |
1 |
|
odds ratio |
1 |
|
oleic acid |
1 |
|
oleic acids/therapeutic use |
1 |
|
ophthalmoplegia/*diagnosis/drug therapy |
1 |
|
ophthalmoplegia/*physiopathology |
1 |
|
orientals |
1 |
|
osteochondrodysplasias/complications/diagnosis |
1 |
|
p-glycoprotein/*genetics |
1 |
|
paroxysmal |
1 |
|
patient acceptance of health care |
1 |
|
patient care team/organization & administration |
1 |
|
pediatric evaluation of disability inventory |
1 |
|
pediatric myasthenia gravis |
1 |
|
pediatrics medical sciences |
1 |
|
peripheral nerves/physiology |
1 |
|
pharmacogenomics |
1 |
|
phototherapy |
1 |
|
phototherapy/*adverse effects/methods |
1 |
|
physical stimulation |
1 |
|
platybasia/*diagnosis |
1 |
|
polyglutamine diseases |
1 |
|
polyhydramnios/etiology |
1 |
|
polymerase chain reaction |
1 |
|
polymorphism |
1 |
|
polymorphism, single nucleotide - genetics |
1 |
|
polymorphism, single nucleotide/*genetics |
1 |
|
polymorphism, single nucleotide/genetics |
1 |
|
polyradiculoneuropathy/*physiopathology |
1 |
|
population |
1 |
|
population surveillance |
1 |
|
population-based |
1 |
|
portugal/epidemiology |
1 |
|
positron-emission tomography |
1 |
|
postoperative complications/ultrasonography |
1 |
|
prednisone/administration & dosage |
1 |
|
pregnancy complications, cardiovascular/drug therapy |
1 |
|
pregnancy complications/*diagnosis |
1 |
|
pregnancy in diabetics |
1 |
|
prevalence among chinese children |
1 |
|
prosopagnosia (pa) |
1 |
|
protocol |
1 |
|
psychiatry |
1 |
|
psychiatry and neurology |
1 |
|
psychotropic agent |
1 |
|
quadriplegia/drug therapy/physiopathology/radionuclide imaging |
1 |
|
quality of life |
1 |
|
radiography, interventional/*adverse effects |
1 |
|
radiopharmaceuticals/diagnostic use |
1 |
|
random allocation |
1 |
|
randomized controlled trials |
1 |
|
randomized controlled trials (rct) |
1 |
|
randomized controlled trials as topic |
1 |
|
rats |
1 |
|
rats, sprague-dawley |
1 |
|
real acupoint (liv3) |
1 |
|
receptors, dopamine d4/*genetics |
1 |
|
receptors, nicotinic/immunology |
1 |
|
rectum |
1 |
|
recurrent bell's palsy |
1 |
|
referral and consultation |
1 |
|
refractive errors |
1 |
|
registries/statistics & numerical data |
1 |
|
rehabiliation |
1 |
|
rehabilitation |
1 |
|
repressor proteins/*genetics |
1 |
|
reproducibility of results |
1 |
|
research |
1 |
|
research design |
1 |
|
rett syndrome |
1 |
|
rett syndrome/*epidemiology/*genetics |
1 |
|
reynell development language scale |
1 |
|
risk |
1 |
|
sacrum/*ultrasonography |
1 |
|
safety |
1 |
|
sbma |
1 |
|
scalp |
1 |
|
scn1a |
1 |
|
scn2a |
1 |
|
scoliosis [*surgery] |
1 |
|
scoliosis/*surgery |
1 |
|
seizures, febrile - etiology - therapy |
1 |
|
seizures/*complications |
1 |
|
seizures/*epidemiology/etiology/therapy |
1 |
|
seizures/etiology |
1 |
|
self care |
1 |
|
serum transferrin |
1 |
|
sex distribution |
1 |
|
sham acupoint |
1 |
|
short latency somatosensory evoked potential (ssep) |
1 |
|
sialorrhea - therapy |
1 |
|
sialorrhea/etiology/*therapy |
1 |
|
siblings |
1 |
|
sickness impact profile |
1 |
|
skin diseases, vascular/*congenital |
1 |
|
skull/pathology |
1 |
|
sleep apnea, central/etiology |
1 |
|
sleep disorders/*etiology/physiopathology |
1 |
|
social interaction |
1 |
|
sodium channels/deficiency/genetics |
1 |
|
sodium/metabolism |
1 |
|
sodium/potassium-transporting atpase |
1 |
|
spasms, infantile/*diagnosis |
1 |
|
spasms, infantile/diagnosis/drug therapy/*epidemiology |
1 |
|
spinal cord tumor |
1 |
|
spinal cord/pathology |
1 |
|
spine [surgery] |
1 |
|
spine/surgery |
1 |
|
status epilepticus/*etiology/physiopathology |
1 |
|
status epilepticus/complications/epidemiology/*etiology/mortality |
1 |
|
status epilepticus/etiology |
1 |
|
stereotypic movement disorder - etiology - therapy |
1 |
|
steroid |
1 |
|
steroids |
1 |
|
stress, psychological/prevention & control |
1 |
|
subarachnoid space/pathology/*ultrasonography |
1 |
|
subgroup classification |
1 |
|
survival analysis |
1 |
|
survival rate |
1 |
|
symbolic play test |
1 |
|
tension-type headache/classification/diagnosis/epidemiology/psychology |
1 |
|
term birth |
1 |
|
terminology as topic |
1 |
|
therapy |
1 |
|
therapy/physiopathology |
1 |
|
thymectomy |
1 |
|
time |
1 |
|
time factors |
1 |
|
tomography, emission-computed, single-photon |
1 |
|
traditional chinese medicine |
1 |
|
traditional chinese medicine (tcm) |
1 |
|
translation initiation factor eif2b |
1 |
|
tuberous sclerosis/*epidemiology |
1 |
|
united states |
1 |
|
vaccine |
1 |
|
vaccines - adverse effects |
1 |
|
valine |
1 |
|
valproic acid/administration & dosage/*adverse effects |
1 |
|
vanishing white matter disease |
1 |
|
verbal behavior/*physiology |
1 |
|
very long chain fatty acid |
1 |
|
vigabatrin |
1 |
|
vigabatrin/therapeutic use |
1 |
|
virus infection |
1 |
|
vision disorders/metabolism/radionuclide imaging/*therapy |
1 |
|
visual cortex/*physiopathology |
1 |
|
visual evoked potential (vep) |
1 |
|
warfarin |
1 |
|
warfarin/*adverse effects/therapeutic use |
1 |
|
young adult |
1 |
|
zinc/analysis/blood/metabolism |
1 |
